Search

Robert E Bitner

from Athol, ID
Age ~66

Robert Bitner Phones & Addresses

  • Athol, ID
  • Lynnwood, WA
  • Seattle, WA
  • Gilroy, CA
  • San Jose, CA
  • 29694 N Greystone Rd, Athol, ID 83801 (208) 699-1177

Work

Position: Sales Occupations

Education

Degree: High school graduate or higher

Professional Records

License Records

Robert Bitner

License #:
E067770 - Expired
Category:
Emergency medical services
Issued Date:
Jun 28, 2010
Expiration Date:
Jul 31, 2012
Type:
Contra Costa County EMS Agency

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert Bitner
Manager
Hilton Worldwide, Inc
Robert Bitner
Manager
Jlb Engineering, Inc
Robert Bitner
3ft. LLC
Robert Bitner
FREE WHEELIN' DREAMS, INC

Publications

Us Patents

Screening Method For Neuroprotective Compounds

View page
US Patent:
52643719, Nov 23, 1993
Filed:
Mar 23, 1992
Appl. No.:
7/855269
Inventors:
George P. Miljanich - Redwood City CA
Robert S. Bitner - Mountain View CA
Stephen S. Bowersox - Menlo Park CA
James A. Fox - Palo Alto CA
Karen L. Valentino - San Carlos CA
Donald H. Yamashiro - San Francisco CA
Makoto Tsubokawa - South San Francisco CA
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
G01N 33567
G01N 3368
US Classification:
436503
Abstract:
A partially purified omega conotoxin binding protein is disclosed. The protein, either in partially purified form or in a synaptosomal preparation, is useful in identifying compounds for use in reducing neuronal damage related to an ischemic condition, such as stroke, in a human patient.

Method Of Suppressing Appetite By Administration Of Tetrahydro-Beta-Carboline Derivatives

View page
US Patent:
49786695, Dec 18, 1990
Filed:
Jun 8, 1989
Appl. No.:
7/363504
Inventors:
Jack D. Barchas - Stanford CA
Glen R. Elliott - Sunnyvale CA
Peter I. Adriaenssens - Palo Alto CA
Robert S. Bitner - Mountain View CA
Stephen S. Bowersox - Menlo Park CA
Laszlo Nadasdi - San Francisco CA
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
A61K 3144
US Classification:
514292
Abstract:
Compounds of formula I are useful for suppressing appetite, for altering macronutrient preferences, for suppressing obsessive-compulsive behavior, and for inhibiting cravings and substance abuse: ##STR1## wherein R. sub. 1 and R. sub. 3 are each independently H, hydroxy-alkyl, alpha-cyanoalkyl, SO. sub. 3 H, SO. sub. 2 NH. sub. 2, or C(O)R, where R is OH, NH. sub. 2, lower alkoxy, benzyloxy, or aliphatic amino acyl; R. sub. 2 and R. sub. 9 are each independently H, lower alkyl, benzyl, succinyl, or C(O)R. sub. 4, where R. sub. 4 is H, lower alkyl, hydrocarboxy-lower alkylene, or lower alkoxycarboxy-lower alkylene; and R. sub. 5, R. sub. 6, R. sub. 7, and R. sub. 8 are each independently H, halo, lower alkyl, hydroxy, lower alkoxy, or two adjacent radicals form methylenedioxy or ethylenedioxy; with the proviso that R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 5, R. sub. 6, R. sub. 7, R. sub. 8, and R. sub. 9 are not simultaneously H.

Delayed Treatment Method Of Reducing Ischemia-Related Neuronal Damage

View page
US Patent:
55590950, Sep 24, 1996
Filed:
Nov 12, 1991
Appl. No.:
7/789913
Inventors:
George P. Miljanich - Redwood CA
Stephen S. Bowersox - Menlo Park CA
James A. Fox - Palo Alto CA
Karen L. Valentino - San Carlos CA
Robert S. Bitner - West Lafayette IN
Donald H. Yamashiro - Cleveland Heights OH
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
A61K 3816
US Classification:
514 12
Abstract:
A method and compositions for reducing neuronal damage related to an ischemic condition in a mammalian subject are described. The method includes administration of a voltage-gated calcium channel-blocking compound to the subject, 4-24 hours after the onset of the ischemic condition. Such a calcium channel blocking compound is effective to block norepinephrine release in mammalian CNS neuronal cells and is characterized by specific, high affinity binding to omega-conotoxin MVIIA binding sites. Also disclosed are novel peptide structures useful in the treatment method of the invention.

Method Of Reducing Neuronal Damage Using Omega Conotoxin Peptides

View page
US Patent:
51890208, Feb 23, 1993
Filed:
Aug 2, 1990
Appl. No.:
7/561766
Inventors:
George P. Miljanich - Redwood City CA
Robert S. Bitner - Mountain View CA
Stephen S. Bowersox - Menlo Park CA
James A. Fox - Palo Alto CA
Karen L. Valentino - San Carlos CA
Donald H. Yamashiro - San Francisco CA
Makoto Tsubokawa - South San Francisco CA
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
A61K 3702
C07K 706
C07K 708
C07K 710
US Classification:
514 12
Abstract:
A partially purified omega conotoxin binding protein is disclosed. The protein, either in partially purified form or in a synaptosomal preparation, is useful in identifying compounds for use in reducing neuronal damage related to an ischemic condition, such as stroke, in a human patient.

Screening Method For Neuroprotective Compounds

View page
US Patent:
54242185, Jun 13, 1995
Filed:
Nov 4, 1993
Appl. No.:
8/147714
Inventors:
George P. Miljanich - Redwood City CA
Robert S. Bitner - Mountain View CA
Stephen S. Bowersox - Menlo Park CA
James A. Fox - Palo Alto CA
Karen L. Valentino - San Carlos CA
Donald H. Yamashiro - San Francisco CA
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
A61K 4900
G01N 33567
G01N 3368
US Classification:
436503
Abstract:
A partially purified omega conotoxin binding protein is disclosed. The protein, either in partially purified form or in a synaptosomal preparation, is useful in identifying compounds for use in reducing neuronal damage related to an ischemic condition, such as stroke, in a human patient.

Method Of Treating Ischemia-Related Neuronal Damage

View page
US Patent:
50514032, Sep 24, 1991
Filed:
Nov 22, 1989
Appl. No.:
7/440094
Inventors:
George P. Miljanich - Redwood City CA
Robert S. Bitner - Mountain View CA
Stephen S. Bowersox - Menlo Park CA
James A. Fox - Palo Alto CA
Karen L. Valentino - San Carlos CA
Donald H. Yamashiro - San Francisco CA
Assignee:
Neurex Corporation - Menlo Park CA
International Classification:
A61K 3702
C07K 708
C07K 710
US Classification:
514 12
Abstract:
A method of reducing neuronal damage related to an ischemic condition in a human patient, such as stroke-induced damage, by administration of a binding/inhibitory omega-conotoxin peptide.
Robert E Bitner from Athol, ID, age ~66 Get Report